Kerri Kissell, MD

Specialties:

Care Provider Overall: 
4.5
Patient Ratings: 
129
  • Clinical Details
  • Education
  • Clinical Trials
Hospital Privileges: 
  • Guthrie Robert Packer Hospital
Clinical Interests: 
  • Endocrine disorders during pregnancy
  • Male and female infertility
  • Menopause, premature menopause and primary ovarian insufficiency
  • Polycystic Ovarian Syndrome
  • Women's Health

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of Recommending Care Provider: 
4.5
Patients' Confidence in Care Provider: 
4.5
Time Care Provider Spent with Patient: 
4.5
Care Provider Spoke Using Clear Language: 
5
Care Provider Efforts to Include in Decisions: 
4.5
Care Provider's Concern for Questions and Worries: 
5
Care Provider's Explanations of Condition/Problem: 
5
Care Provider Information About Medications: 
4.5
Care Provider Instructions for Follow-Up Care: 
4.5
Care Provider's Friendliness and Courtesy: 
5
Residency: 
  • University of Maryland Medical Center, Baltimore, Md. (Internal Medicine)
Certification: 
  • American Board of Internal Medicine
  • American Board of Endocrinology, Diabetes and Metabolism
Education: 
  • Drexel University College of Medicine (DUCOM), Philadelphia, Pa.
Internship: 
  • University of Maryland Medical Center, Baltimore, Md. (Internal Medicine)
Fellowship: 
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health, Bethesda, Md. (Adult Endocrinology)
Department: Endocrinology
Diagnosis: Diabetes
Principal Investigator: Kissell MD, Kerri
Sub-Investigator(s):
  • Fanelli CRNP, Josephine
  • Parsamehr MD, Behnaz
  • Talluri MD, Swapna
Sponsor: Sanofi Aventis
Details (Identifier #): NCT02451137
Title: A randomized, open-label, parallel group real world pragmatic trial to assess the clinical and health outcomes of Toujeo® compared to commercially available basal insulins for initiation of therapy in insulin naïve patients with uncontrolled type 2 diabetes mellitus Protocol LPS14347